Laulund, Anne Sofie
Novo Nordisk (Denmark)
4 papers on CoChatORCID 0000-0002-4556-9968
Most cited papers
- Verified
Low Serum Thyrotropin Level and Duration of Suppression as a Predictor of Major Osteoporotic Fractures—The OPENTHYRO Register Cohort
Abrahamsen, B., Jørgensen, H. L., Laulund, A. S., Nybo, M., Brix, T. H., & Hegedüs, L. (2014) · Journal of Bone and Mineral Research
Bone health and osteoporosis researchThyroid Disorders and Treatments
Cited by 112
- Verified
The Excess Risk of Major Osteoporotic Fractures in Hypothyroidism Is Driven by Cumulative Hyperthyroid as Opposed to Hypothyroid Time: An Observational Register-Based Time-Resolved Cohort Analysis
Abrahamsen, B., Jørgensen, H. L., Laulund, A. S., Nybo, M., Bauer, D. C., Brix, T. H., & Hegedüs, L. (2015) · Journal of Bone and Mineral Research
Thyroid Disorders and TreatmentsBone health and osteoporosis research
Cited by 98
- Verified
Duration of Thyroid Dysfunction Correlates with All-Cause Mortality. The OPENTHYRO Register Cohort
Laulund, A. S., Nybo, M., Brix, T. H., Abrahamsen, B., Jørgensen, H. L., & Hegedüs, L. (2014) · PLoS ONE
Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery
Cited by 70
- Verified
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial
Aroda, V. R., Jørgensen, N. B., Kumar, B., Lingvay, I., Laulund, A. S., Buse, J. B., & trial investigators (2025) · Diabetes Care
Diabetes Treatment and ManagementPharmacology and Obesity Treatment
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free